Skip to content

Spinal Stimulation in Chronic Spinal Cord Injury

Non-invasive Spinal Cord Stimulation Combined With Activity-based Rehabilitation in Chronic Spinal Cord Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04132596
Enrollment
12
Registered
2019-10-21
Start date
2019-11-11
Completion date
2022-10-03
Last updated
2022-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Brief summary

Electrical spinal stimulation combined with activity-based rehabilitation (ABR) can improve motor and autonomic function in individuals suffering from varying degrees of paralysis. Spinal stimulation studies have included invasive implanted devices and non-invasive transcutaneous systems using different combinations of stimulation current, waveform, amplitude, duration and spinal levels targeted. Invasive and non-invasive systems have been demonstrated to permit individuals with chronic spinal cord injury (SCI), previously considered to have complete injuries on the International Standards for the Neurological Classification of Spinal Cord Injuries (ISNCSCI) scale (Classification A), to regain some degree of voluntary and autonomic function during periods of stimulation. The aim of this study is to evaluate the effects of a novel non-invasive transcutaneous electrical spinal cord stimulation system (tSCS) combined with activity-based rehabilitation in patients who have paralysis of their legs and/or arms. We will examine participants for any changes in sensory, motor or autonomic function. We will use a transcutaneous spinal cord stimulator that has been designed to deliver safe and tolerable bursts of high frequency pulsed current that minimise the capacitance efforts of the skin surface and maximise conductance of a second waveform using low frequency current to target neural structures. We aim to investigate this form of neuromodulation with a small group of individuals with chronic spinal cord injury. Our goal is to observe and describe any short term or lasting changes in function that can safely and comfortably be derived from this combination of spinal stimulation and activity-based rehabilitation. If this therapy can cause lasting improvements in sensory, motor, respiratory or autonomic function, then this may lead to a greater degree of functional independence for these individuals.

Interventions

DEVICETranscutaneous spinal cord stimulation

Electrical stimulation of the spinal cord via transcutaneous hydrogel electrodes

Physical therapy

Sponsors

International Spinal Research Trust
CollaboratorOTHER
The Neurokinex Charitable Trust
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Cohort study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant is willing and able to give informed consent for participation in the study * Aged 18 years or over * Injury level C4-T12 * At least one year post spinal cord injury * Medically stable and cognitively intact * Independent respiration, not requiring any ventilatory support

Exclusion criteria

* Any active implanted metallic device including, but not limited to neurostimulators, cochlear implants, pacemakers, implantable defibrillators or drug delivery pump * Implanted surgical hardware that is not compatible with MRI scanners * Possible, suspected or confirmed pregnancy and/or lactation * Active Heterotopic Ossification * Recent history or fracture, contractures or pressure sore, deep vein thrombosis or urinary tract or other infection that may interfere with the intervention and training. * History of epilepsy and/or seizures. * Severe spasticity which have been unstable over the past 3 months prior to enrolment and not expected to change; taking varying doses of anti-spasticity medications which could not be tapered to a stable dose and is not expected to change * Botulinum toxin injections within 6 months of participation (excluding bladder) * Non-injury related neurological impairment * Clinically significant severe depression in spite of treatment * Patients who have cardiovascular disease * Patients with Autonomic Dysreflexia that is severe, ongoing and has required medical treatment within the past one month * Active aggressive tumour within or surrounding the spinal cord or brain stem * A syrinx (fluid filled cavity) in the spinal cord * Skin conditions or allergies that may affect electrode placement * Bodyweight over 120kg (due to inability to use some of the study equipment) * Patients who do not understand English

Design outcomes

Primary

MeasureTime frameDescription
Electromyography (EMG) of muscle activity1 yearUpper limb, trunk and lower limb EMG using the Delsys Trigno System
NeuroRecovery Scale (NRS)1 yearFunctional independence measure rated from 1a, the lowest classification of functioning to 4C, the highest classification of functioning
Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP) Test1 yearUpper limb measure of sensation and function. Strength scored 0-100, sensation scored 0-24 and prehension scored 0-64. Increased score relates to increased hand strength, sensation and function
Capabilities of Upper Extremity Questionnaire (CUE)1 yearUpper limb capability questionnaire with 32 items. Scores between 32-124 with higher scores associated with higher levels of function of the upper limb
Force dynamometry - hand1 yearGrip and pinch strength using JTech force transducers. Measurements taken in Newtons
International Standards for the Neurological Classification of Spinal Cord Injury Classification scores (ISNCSCI ASIA chart)1 yearSensory and motor scores. Sensory scale 0-224, motor scale 0-100 with higher scores relating to increased sensation and motor power
Spinal Cord Independence Measure (SCIM)1 yearFunctional independence tool for spinal cord injury. Scale of 0-100, with higher scores meaning increased function
Berg Balance Score (where applicable)1 yearMeasure of standing balance. Scale of 0-56, with higher values meaning increased standing balance and reduced risk of falls

Secondary

MeasureTime frameDescription
International Spinal Cord Society Autonomic Standards Assessment Form1 yearBladder function questionnaire to document method of bladder management
Modified Ashworth Scale1 yearSpasticity measure, scores of 0 - no increase in spasticity to 4 - affected part rigid
Respiratory function tests of maximal inspiratory and expiratory pressures1 yearMaximal inspiratory and expiratory pressures in breathing,
World Health Organisation Quality Of Life - BREF (WHOQOL-BREF)1 yearQuality of Life self report questionnaire with 26 items, subdivided into Physical Health (raw score range 7-35), Psychological Health (raw score range 6-30), Social Relationships (raw score range 3-15), Environment (raw score range 8-40)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026